{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:13:03Z","timestamp":1795111983877,"version":"4.10.3"},"reference-count":59,"publisher":"American Association for Cancer Research (AACR)","issue":"24","license":[{"start":{"date-parts":[[2022,12,16]],"date-time":"2022-12-16T00:00:00Z","timestamp":1671148800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C11512\/A20256"],"award-info":[{"award-number":["C11512\/A20256"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C21825\/A239"],"award-info":[{"award-number":["C21825\/A239"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"crossref","award":["C21825\/A279"],"award-info":[{"award-number":["C21825\/A279"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"crossref","award":["M506"],"award-info":[{"award-number":["M506"]}],"id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wessex Medical Research","award":["S07"],"award-info":[{"award-number":["S07"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,12,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>Myofibroblastic cancer-associated fibroblast (myoCAF)\u2013rich tumors generally contain few T cells and respond poorly to immune-checkpoint blockade. Although myoCAFs are associated with poor outcome in most solid tumors, the molecular mechanisms regulating myoCAF accumulation remain unclear, limiting the potential for therapeutic intervention. Here, we identify ataxia-telangiectasia mutated (ATM) as a central regulator of the myoCAF phenotype. Differentiating myofibroblasts in vitro and myoCAFs cultured ex vivo display activated ATM signaling, and targeting ATM genetically or pharmacologically could suppress and reverse differentiation. ATM activation was regulated by the reactive oxygen species\u2013producing enzyme NOX4, both through DNA damage and increased oxidative stress. Targeting fibroblast ATM in vivo suppressed myoCAF-rich tumor growth, promoted intratumoral CD8 T-cell infiltration, and potentiated the response to anti\u2013PD-1 blockade and antitumor vaccination. This work identifies a novel pathway regulating myoCAF differentiation and provides a rationale for using ATM inhibitors to overcome CAF-mediated immunotherapy resistance.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>ATM signaling supports the differentiation of myoCAFs to suppress T-cell infiltration and antitumor immunity, supporting the potential clinical use of ATM inhibitors in combination with checkpoint inhibition in myoCAF-rich, immune-cold tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-22-0435","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T02:07:27Z","timestamp":1668046047000},"page":"4571-4585","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["ATM Regulates Differentiation of Myofibroblastic Cancer-Associated Fibroblasts and Can Be Targeted to Overcome Immunotherapy Resistance"],"prefix":"10.1158","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4964-9340","authenticated-orcid":false,"given":"Massimiliano","family":"Mellone","sequence":"first","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-9890","authenticated-orcid":false,"given":"Klaudia","family":"Piotrowska","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1624-8946","authenticated-orcid":false,"given":"Giulia","family":"Venturi","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3574-1565","authenticated-orcid":false,"given":"Lija","family":"James","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5836-4905","authenticated-orcid":false,"given":"Aleksandra","family":"Bzura","sequence":"additional","affiliation":[{"name":"2Department of Genetics and Genome Biology, Cancer Research Centre, University of Leicester, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4398-775X","authenticated-orcid":false,"given":"Maria A.","family":"Lopez","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0032-5935","authenticated-orcid":false,"given":"Sonya","family":"James","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3811-7725","authenticated-orcid":false,"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[{"name":"3Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5264-0531","authenticated-orcid":false,"given":"Matthew J.","family":"Ellis","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3816-7220","authenticated-orcid":false,"given":"Christopher J.","family":"Hanley","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6314-973X","authenticated-orcid":false,"given":"Josephine F.","family":"Buckingham","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0492-3024","authenticated-orcid":false,"given":"Kerry L.","family":"Cox","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1938-8039","authenticated-orcid":false,"given":"Gareth","family":"Hughes","sequence":"additional","affiliation":[{"name":"4Bioscience, Oncology Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6661-6033","authenticated-orcid":false,"given":"Viia","family":"Valge-Archer","sequence":"additional","affiliation":[{"name":"4Bioscience, Oncology Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0658-1873","authenticated-orcid":false,"given":"Emma V.","family":"King","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3765-3342","authenticated-orcid":false,"given":"Stephen A.","family":"Beers","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2229-2406","authenticated-orcid":false,"given":"Vincent","family":"Jaquet","sequence":"additional","affiliation":[{"name":"5Department of Pathology and Immunology, Centre M\u00e9dical Universitaire, Gen\u00e8ve, Switzerland."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9543-2206","authenticated-orcid":false,"given":"George D.D.","family":"Jones","sequence":"additional","affiliation":[{"name":"2Department of Genetics and Genome Biology, Cancer Research Centre, University of Leicester, Leicester, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-4769","authenticated-orcid":false,"given":"Natalia","family":"Savelyeva","sequence":"additional","affiliation":[{"name":"3Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-1485","authenticated-orcid":false,"given":"Emre","family":"Sayan","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5052-1125","authenticated-orcid":false,"given":"Jason L.","family":"Parsons","sequence":"additional","affiliation":[{"name":"3Department of Molecular and Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, Liverpool, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4209-7499","authenticated-orcid":false,"given":"Stephen","family":"Durant","sequence":"additional","affiliation":[{"name":"4Bioscience, Oncology Innovative Medicines and Early Development (IMED) Biotech Unit, AstraZeneca, Cambridge, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3832-7335","authenticated-orcid":false,"given":"Gareth J.","family":"Thomas","sequence":"additional","affiliation":[{"name":"1School of Cancer Sciences, Faculty of Medicine, University of Southampton, Southampton, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2022,11,10]]},"reference":[{"key":"2025112417343339700_bib1","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-cancerbio-050216-034359","article-title":"Immune-suppressing cellular elements of the tumor microenvironment","volume":"1","author":"Fearon","year":"2017","journal-title":"Ann Rev Cancer Biol"},{"key":"2025112417343339700_bib2","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","article-title":"The biology and function of fibroblasts in cancer","volume":"16","author":"Kalluri","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"2025112417343339700_bib3","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","article-title":"Recent developments in myofibroblast biology: paradigms for connective tissue remodeling","volume":"180","author":"Hinz","year":"2012","journal-title":"Am J Pathol"},{"key":"2025112417343339700_bib4","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/path.2830","article-title":"Stromal features are predictive of disease mortality in oral cancer patients","volume":"223","author":"Marsh","year":"2011","journal-title":"J Pathol"},{"key":"2025112417343339700_bib5","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/path.4467","article-title":"Cancer-associated fibroblasts predict poor outcome and promote periostin-dependent invasion in oesophageal adenocarcinoma","volume":"235","author":"Underwood","year":"2015","journal-title":"J Pathol"},{"key":"2025112417343339700_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s12282-010-0234-5","article-title":"Role of stromal myofibroblasts in invasive breast cancer: stromal expression of alpha-smooth muscle actin correlates with worse clinical outcome","volume":"19","author":"Yamashita","year":"2012","journal-title":"Breast Cancer"},{"key":"2025112417343339700_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"2025112417343339700_bib8","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nature25501","article-title":"TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"2025112417343339700_bib9","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.cell.2017.01.010","article-title":"Genomic and transcriptomic features of response to anti-pd-1 therapy in metastatic melanoma","volume":"168","author":"Hugo","year":"2017","journal-title":"Cell"},{"key":"2025112417343339700_bib10","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat Commun"},{"key":"2025112417343339700_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-19-0644","article-title":"Single-cell RNA sequencing reveals stromal evolution into lrrc15(+) myofibroblasts as a determinant of patient response to cancer immunotherapy","volume":"10","author":"Dominguez","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112417343339700_bib12","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","article-title":"Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer","volume":"10","author":"Kieffer","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112417343339700_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/nature25492","article-title":"TGFbeta drives immune evasion in genetically reconstituted colon cancer metastasis","volume":"554","author":"Tauriello","year":"2018","journal-title":"Nature"},{"key":"2025112417343339700_bib14","doi-asserted-by":"crossref","DOI":"10.1158\/0008-5472.CAN-19-3158","article-title":"NOX4 inhibition potentiates immunotherapy by overcoming cancer-associated fibroblast-mediated CD8 T-cell exclusion from tumors","author":"Ford","year":"2020","journal-title":"Cancer Res"},{"key":"2025112417343339700_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/cancers5010149","article-title":"Carcinoma-associated fibroblasts are a promising therapeutic target","volume":"5","author":"Togo","year":"2013","journal-title":"Cancers (Basel)"},{"key":"2025112417343339700_bib16","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.4161\/cbt.6.11.4874","article-title":"Phase II trial of single-agent Val-boroPro (talabostat) inhibiting fibroblast activation protein in patients with metastatic colorectal cancer","volume":"6","author":"Narra","year":"2007","journal-title":"Cancer Biol Ther"},{"key":"2025112417343339700_bib17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.4161\/cbt.5.12.3354","article-title":"Identification of fibroblast heterogeneity in the tumor microenvironment","volume":"5","author":"Sugimoto","year":"2006","journal-title":"Cancer Biol Ther"},{"key":"2025112417343339700_bib18","doi-asserted-by":"crossref","first-page":"e90353","DOI":"10.1371\/journal.pone.0090353","article-title":"Phase I study of GC1008 (fresolimumab): a human anti-transforming growth factor-beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma","volume":"9","author":"Morris","year":"2014","journal-title":"PLoS One"},{"key":"2025112417343339700_bib19","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1200\/JCO.2015.62.8719","article-title":"Randomized phase Ib\/II study of gemcitabine plus placebo or vismodegib, a hedgehog pathway inhibitor, in patients with metastatic pancreatic cancer","volume":"33","author":"Catenacci","year":"2015","journal-title":"J Clin Oncol"},{"key":"2025112417343339700_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.18632\/aging.101127","article-title":"Induction of fibroblast senescence generates a non-fibrogenic myofibroblast phenotype that differentially impacts on cancer prognosis","volume":"9","author":"Mellone","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"2025112417343339700_bib21","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/nature08467","article-title":"The DNA-damage response in human biology and disease","volume":"461","author":"Jackson","year":"2009","journal-title":"Nature"},{"key":"2025112417343339700_bib22","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.molcel.2017.05.015","article-title":"ATM, ATR, and DNA-PK: the trinity at the heart of the DNA damage response","volume":"66","author":"Blackford","year":"2017","journal-title":"Mol Cell"},{"key":"2025112417343339700_bib23","doi-asserted-by":"crossref","first-page":"re5","DOI":"10.1126\/scisignal.2005474","article-title":"New tricks for an old fox: impact of TGFbeta on the DNA damage response and genomic stability","volume":"7","author":"Barcellos-Hoff","year":"2014","journal-title":"Sci Signal"},{"key":"2025112417343339700_bib24","doi-asserted-by":"crossref","first-page":"10861","DOI":"10.1158\/0008-5472.CAN-06-2565","article-title":"Inhibition of transforming growth factor-beta1 signaling attenuates ataxia telangiectasia mutated activity in response to genotoxic stress","volume":"66","author":"Kirshner","year":"2006","journal-title":"Cancer Res"},{"key":"2025112417343339700_bib25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1038\/onc.2015.162","article-title":"IFNgamma induces oxidative stress, DNA damage and tumor cell senescence via TGFbeta\/SMAD signaling-dependent induction of Nox4 and suppression of ANT2","volume":"35","author":"Hubackova","year":"2016","journal-title":"Oncogene"},{"key":"2025112417343339700_bib26","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/carcin\/bgp192","article-title":"Intercellular communication of cellular stress monitored by gamma-H2AX induction","volume":"30","author":"Dickey","year":"2009","journal-title":"Carcinogenesis"},{"key":"2025112417343339700_bib27","doi-asserted-by":"crossref","first-page":"e12838","DOI":"10.1111\/acel.12838","article-title":"Telomere dysfunction promotes transdifferentiation of human fibroblasts into myofibroblasts","volume":"17","author":"Razdan","year":"2018","journal-title":"Aging Cell"},{"key":"2025112417343339700_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx121","article-title":"Targeting the myofibroblastic cancer-associated fibroblast phenotype through inhibition of NOX4","volume":"110","author":"Hanley","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"2025112417343339700_bib29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1146\/annurev-biochem-060614-034335","article-title":"Mechanisms of ATM Activation","volume":"84","author":"Paull","year":"2015","journal-title":"Annu Rev Biochem"},{"key":"2025112417343339700_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","article-title":"DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation","volume":"421","author":"Bakkenist","year":"2003","journal-title":"Nature"},{"key":"2025112417343339700_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1126\/science.1192912","article-title":"ATM activation by oxidative stress","volume":"330","author":"Guo","year":"2010","journal-title":"Science"},{"key":"2025112417343339700_bib32","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1158\/1535-7163.MCT-05-0081","article-title":"Reversal of cisplatin resistance with a BH3 mimetic, (-)-gossypol, in head and neck cancer cells: role of wild-type p53 and Bcl-xL","volume":"4","author":"Bauer","year":"2005","journal-title":"Mol Cancer Ther"},{"key":"2025112417343339700_bib33","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/BJ20061903","article-title":"NOX4 activity is determined by mRNA levels and reveals a unique pattern of ROS generation","volume":"406","author":"Serrander","year":"2007","journal-title":"Biochem J"},{"key":"2025112417343339700_bib34","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00262-017-2111-y","article-title":"Linear doggybone DNA vaccine induces similar immunological responses to conventional plasmid DNA independently of immune recognition by TLR9 in a pre-clinical model","volume":"67","author":"Allen","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"2025112417343339700_bib35","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1093\/carcin\/bgt035","article-title":"Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-beta","volume":"34","author":"Hassona","year":"2013","journal-title":"Carcinogenesis"},{"key":"2025112417343339700_bib36","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.4161\/cc.9.24.14323","article-title":"ATM activation in the presence of oxidative stress","volume":"9","author":"Guo","year":"2010","journal-title":"Cell Cycle"},{"key":"2025112417343339700_bib37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/2159-8290.CD-18-0710","article-title":"IL1-induced JAK\/STAT signaling is antagonized by TGFbeta to shape CAF heterogeneity in pancreatic ductal adenocarcinoma","volume":"9","author":"Biffi","year":"2019","journal-title":"Cancer Discov"},{"key":"2025112417343339700_bib38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1158\/0008-5472.CAN-10-1252","article-title":"CCT241533 is a potent and selective inhibitor of CHK2 that potentiates the cytotoxicity of PARP inhibitors","volume":"71","author":"Anderson","year":"2011","journal-title":"Cancer Res"},{"key":"2025112417343339700_bib39","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.gene.2014.02.026","article-title":"A far-upstream AP-1\/Smad binding box regulates human NOX4 promoter activation by transforming growth factor-beta","volume":"540","author":"Bai","year":"2014","journal-title":"Gene"},{"key":"2025112417343339700_bib40","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","article-title":"Cross-species single-cell analysis of pancreatic ductal adenocarcinoma reveals antigen-presenting cancer-associated fibroblasts","volume":"9","author":"Elyada","year":"2019","journal-title":"Cancer Discov"},{"key":"2025112417343339700_bib41","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J Clin Invest"},{"key":"2025112417343339700_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.matbio.2011.10.004","article-title":"Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration","volume":"31","author":"Evanko","year":"2012","journal-title":"Matrix Biol"},{"key":"2025112417343339700_bib43","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1128\/MCB.00347-10","article-title":"Requirement of the ATM\/p53 tumor suppressor pathway for glucose homeostasis","volume":"30","author":"Armata","year":"2010","journal-title":"Mol Cell Biol"},{"key":"2025112417343339700_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aan5598","article-title":"ATM directs DNA damage responses and proteostasis via genetically separable pathways","volume":"11","author":"Lee","year":"2018","journal-title":"Sci Signal"},{"key":"2025112417343339700_bib45","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.tcb.2011.01.004","article-title":"Regulation of cell differentiation by the DNA damage response","volume":"21","author":"Sherman","year":"2011","journal-title":"Trends Cell Biol"},{"key":"2025112417343339700_bib46","doi-asserted-by":"crossref","first-page":"13666","DOI":"10.18632\/oncotarget.24446","article-title":"Persistent DNA strand breaks induce a CAF-like phenotype in normal fibroblasts","volume":"9","author":"Legrand","year":"2018","journal-title":"Oncotarget"},{"key":"2025112417343339700_bib47","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1080\/15384101.2015.1041685","article-title":"Oxidized ATM promotes abnormal proliferation of breast CAFs through maintaining intracellular redox homeostasis and activating the PI3K-AKT, MEK-ERK, and Wnt-beta-catenin signaling pathways","volume":"14","author":"Tang","year":"2015","journal-title":"Cell Cycle"},{"key":"2025112417343339700_bib48","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1038\/s41416-018-0042-9","article-title":"Quantitative proteomic profiling of primary cancer-associated fibroblasts in oesophageal adenocarcinoma","volume":"118","author":"Manousopoulou","year":"2018","journal-title":"Br J Cancer"},{"key":"2025112417343339700_bib49","doi-asserted-by":"crossref","first-page":"e60321","DOI":"10.1371\/journal.pone.0060321","article-title":"Biological characteristics and genetic heterogeneity between carcinoma-associated fibroblasts and their paired normal fibroblasts in human breast cancer","volume":"8","author":"Peng","year":"2013","journal-title":"PLoS One"},{"key":"2025112417343339700_bib50","doi-asserted-by":"crossref","first-page":"ra84","DOI":"10.1126\/scisignal.2004592","article-title":"Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis","volume":"7","author":"Svegliati","year":"2014","journal-title":"Sci Signal"},{"key":"2025112417343339700_bib51","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.4161\/cc.20259","article-title":"The DNA damage checkpoint protein ATM promotes hepatocellular apoptosis and fibrosis in a mouse model of non-alcoholic fatty liver disease","volume":"11","author":"Daugherity","year":"2012","journal-title":"Cell Cycle"},{"key":"2025112417343339700_bib52","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1096\/fj.14-262527","article-title":"Tumor suppressor ataxia telangiectasia mutated functions downstream of TGF-beta1 in orchestrating profibrotic responses","volume":"29","author":"Overstreet","year":"2015","journal-title":"FASEB J"},{"key":"2025112417343339700_bib53","doi-asserted-by":"crossref","first-page":"6315","DOI":"10.1038\/s41467-020-19920-5","article-title":"TGFbeta-blockade uncovers stromal plasticity in tumors by revealing the existence of a subset of interferon-licensed fibroblasts","volume":"11","author":"Grauel","year":"2020","journal-title":"Nat Commun"},{"key":"2025112417343339700_bib54","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1186\/s12885-016-2614-5","article-title":"CHEK2 represses breast stromal fibroblasts and their paracrine tumor-promoting effects through suppressing SDF-1 and IL-6","volume":"16","author":"Al-Rakan","year":"2016","journal-title":"BMC Cancer"},{"key":"2025112417343339700_bib55","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1177\/0192623311416259","article-title":"Induction of heart valve lesions by small-molecule ALK5 inhibitors","volume":"39","author":"Anderton","year":"2011","journal-title":"Toxicol Pathol"},{"key":"2025112417343339700_bib56","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-19-1353","article-title":"Fibroblast heterogeneity in the pancreatic tumor microenvironment","volume":"10","author":"Helms","year":"2020","journal-title":"Cancer Discov"},{"key":"2025112417343339700_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41571-018-0114-z","article-title":"State-of-the-art strategies for targeting the DNA damage response in cancer","volume":"16","author":"Pili\u00e9","year":"2019","journal-title":"Nat Rev Clin Oncol"},{"key":"2025112417343339700_bib58","doi-asserted-by":"crossref","DOI":"10.1172\/JCI139333","article-title":"ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS\/STING activation","volume":"131","author":"Hu","year":"2021","journal-title":"J Clin Invest"},{"key":"2025112417343339700_bib59","doi-asserted-by":"crossref","first-page":"eaat1719","DOI":"10.1126\/sciadv.aat1719","article-title":"The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models","volume":"4","author":"Durant","year":"2018","journal-title":"Sci Adv"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/doi\/10.1158\/0008-5472.CAN-22-0435\/3225557\/can-22-0435.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/24\/4571\/3230701\/4571.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/82\/24\/4571\/3230701\/4571.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T22:34:45Z","timestamp":1764023685000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/82\/24\/4571\/711530\/ATM-Regulates-Differentiation-of-Myofibroblastic"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,10]]},"references-count":59,"journal-issue":{"issue":"24","published-online":{"date-parts":[[2022,11,10]]},"published-print":{"date-parts":[[2022,12,16]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-22-0435","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22432566.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432572.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432575.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514176","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432569.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432575","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432581","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432578.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432581.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432569","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432572","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6514176.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432566","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22432578","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.30699218","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699248","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699224","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699236","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699242","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699251","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699239","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699227","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699233","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699245","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699221","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.30699230","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,10]]}}}